文献速递神经儿科影像MR

垂体MRI影像组学提高矮小症儿童生长激素缺乏症的诊断效能:一项多中心影像组学研究

Pituitary MRI Radiomics Improves Diagnostic Performance of Growth Hormone Deficiency in Children Short Stature: A Multicenter Radiomics Study.
PubMed 文献 · Acad Radiol · 2024-05-25

本研究回顾性纳入训练与验证队列共297例生长激素缺乏症(GHD)和300例特发性矮小(ISS)儿童,并采用另一机构49例GHD和51例ISS作为外部测试队列,基于矢状位T1加权图像提取垂体前叶影像组学特征构建模型。临床-影像组学模型在训练和验证队列的AUC分别为0.820和0.801,与影像组学模型(AUC=0.812和0.779)相当且均优于临床模型,在测试队列中临床-影像组学模型AUC最高(0.762)。结论认为将常规垂体MRI影像组学特征与临床指标整合,可为识别GHD提供微创方法并在多中心环境中表现稳健。

要点

  • 临床-影像组学模型在训练和验证队列AUC为0.820和0.801,与影像组学模型相当且均优于临床模型。
  • 外部测试队列中临床-影像组学模型AUC为0.762,高于影像组学模型0.741和临床模型0.604。
  • 影像组学特征提取自矢状位T1加权图像上的垂体前叶,场强为1.5 T或3.0 T。

核心结论

  • 将常规垂体MRI影像组学特征与临床指标整合,可为识别GHD提供微创方法,并在多中心环境中表现稳健。

研究设计与样本

  • 回顾性队列研究,训练与验证队列按8:2比例纳入297例GHD和300例ISS儿童(4-12岁),外部测试队列来自另一机构共49例GHD和51例ISS。

关键影像表现/征象

  • 影像组学特征提取自矢状位T1加权图像上的垂体前叶,设备场强为1.5 T或3.0 T。

诊断标准与关键数值

  • 影像组学模型经特征选择后纳入17个影像组学特征。
  • 临床模型采用总蛋白、总胆固醇、游离三碘甲状腺原氨酸和甘油三酯构建。
  • 训练队列AUC:临床-影像组学模型0.820,影像组学模型0.812,临床模型0.575。
  • 验证队列AUC:临床-影像组学模型0.801,影像组学模型0.779,临床模型0.593。
  • 测试队列AUC:临床-影像组学模型0.762,影像组学模型0.741,临床模型0.604。

临床应用与阅片要点

  • 在训练和验证队列中,临床-影像组学模型与影像组学模型诊断效能相当(均P>0.05),两者均优于临床模型(P<0.001)。
  • 在测试队列中,临床-影像组学模型AUC高于临床模型和影像组学模型(P<0.05)。
  • 在测试队列中,临床模型与影像组学模型诊断效能相似(P>0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To develop an efficient machine-learning model using pituitary MRI radiomics and clinical data to differentiate growth hormone deficiency (GHD) from idiopathic short stature (ISS), making the diagnostic process more acceptable to patients and their families.

MATERIALS AND METHODS: A retrospective cohort of 297 GHD and 300 ISS children (4-12 years) were enrolled as training and validation cohorts (8:2 ratio). An external cohort from another institution (49 GHD and 51 ISS) was employed as the testing cohort. Radiomics features extracted from the anterior pituitary gland on sagittal T1-weighted image (1.5 T or 3.0 T) were used to develop a radiomics model after feature selection. Hematological biomarkers were selected to create a clinical model and combine with the optimal radiomics features to create a clinical-radiomics model. The area under the receive operating characteristic curve (AUC) and Delong test compared the diagnostic performance of the previously mentioned three models across different validation and testing cohorts.

RESULTS: 17 radiomics features were selected for the radiomics model, and total protein, total cholesterol, free triiodothyronine, and triglyceride were utilized for the clinical model. In the training and validation cohorts, the diagnostic performance of the clinical-radiomics model (AUC=0.820 and 0.801) was comparable to the radiomics model (AUC=0.812 and 0.779, both P >0.05), both outperforming the clinical model (AUC=0.575 and 0.593, P <0.001). In the testing cohort, the clinical-radiomics model exhibited the highest AUC of 0.762 than the clinical and radiomics model (AUC=0.604 and 0.741, respectively, P <0.05). In addition, the clinical and radiomics models demonstrated similar diagnostic performance in the testing cohort (P >0.05).

CONCLUSION: Integrating radiomics features from conventional pituitary MRI with clinical indicators offers a minimally invasive approach for identifying GHD and shows robustness in a multicenter setting.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Shu K, Wang K, Zhang R, et al. Pituitary MRI Radiomics Improves Diagnostic Performance of Growth Hormone Deficiency in Children Short Stature: A Multicenter Radiomics Study. Acad Radiol. 2024. PMID: 38796401. doi:10.1016/j.acra.2024.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。